MEBO International Hosts Brand Launch and New Year Gala in Singapore
Participants included professionals from Singapore General Hospital, Tan Tock Seng Hospital, the National University of Singapore Yong Loo Lin School of Medicine, Woodlands Health Campus, KK Women’s and Children’s Hospital, and Tai Ho Guan Hospital, highlighting strong engagement across both Eastern and Western medical systems.
Strategic Alignment and Regulatory Progress
The event opened with a corporate presentation showcasing MEBO International’s nearly four decades of innovation in regenerative medicine and wound repair, its global resource network, and long-term development vision.
Lim Ai Neo, President of the Singapore Chinese Chamber of Commerce & Industry for Chinese Medicine and Health Products, expressed strong recognition of MEBO International’s entry into the Singapore market. He noted that MEBO’s long-term research strengths in regenerative medicine and wound care align closely with the development priorities of Singapore’s healthcare system, and voiced expectations that MEBO would contribute meaningful value to local healthcare advancement.
MEBO’s advancement in Singapore is supported by sustained high-level engagement. In 2016, MEBO Group Chairman Kevin Xu met with then–Prime Minister Lee Hsien Loong, initiating strategic dialogue. This relationship was further strengthened in 2023 during the APEC meetings, providing a solid foundation for MEBO’s long-term development in Singapore and Southeast Asia.
At the regulatory level, Vice Chairwoman Li Li led key engagement efforts, successfully facilitating pathways for product registration and compliance, enabling localized market entry and sustainable operations.
Brand Launch and Regional Outlook
MEBO International officially launched its Singapore brand during the event, signaling its transition into systematic, long-term local operations. Congratulatory messages from global partners across more than ten countries underscored MEBO’s expanding international presence.
Positioned as a regional hub, Singapore will serve as a strategic anchor for MEBO International to further advance research collaboration, clinical application, and international partnerships in regenerative medicine across the Asia-Pacific region.
About MEBO
Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.
At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.
As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.
stay informed. connect with us.
